Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026

Digital Poster

Image Analysis for Alzheimer's and Parkinson's

Back to the Program-at-a-Glance

Image Analysis for Alzheimer's and Parkinson's
Digital Poster
Analysis Methods
Tuesday, 12 May 2026
Digital Posters Row F
14:35 - 15:30
Session Number: 465-04
No CME/CE Credit
This session will present the development and validation of image analysis tools for the analysis of Alzheimer’s disease and Parkinson’s disease.

  Figure 465-04-001.  Signed Network Analysis Reveals Compensatory Responses of Default Mode Network Functional Connectivity to Amyloid Deposition
Hasan Jafari, Ali Reihanian, Gloria Chiang, Tracy Butler, Sudhin Shah, Seyed Javad Moosania Zare, Liangdong Zhou, Yi Li, Seyed Hani Hojjati
Arak University, Arak, Iran (Islamic Republic of)
Impact: This work demonstrates a compensatory response of the brain's default mode network functional connectivity to amyloid deposition. Using signed network metrics may improve early detection of pathological brain reorganization and guide future network-based therapeutic strategies.
  Figure 465-04-002.  Improving Diagnostic Confidence in Neuroimaging with MR-Guided PET Reconstruction
Matthew Spangler-Bickell, Daniel Litwiller, Jack McCarty, Guido Davidzon, Greg Zaharchuk, Kip Guja, Mehdi Khalighi, Farshad Moradi
GE HealthCare, Waukesha, United States of America
Impact: MR-guided PET image reconstruction improves image quality and diagnostic confidence in focal or regional anomaly detection in epilepsy and dementia.
  Figure 465-04-003.  Probing cellular microstructure via time-dependent diffusion MRS and machine learning based modeling in Alzheimer’s disease
Ke Zhou, Tiantian Hua, Yaou Liu, Yi-Cheng Hsu, Mengye Lyu, Min Wang
College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, China
Impact: This work provides a unique insight into the Td-dependency of intracellular metabolites and water to probe the microstructural changes during the early presymptomatic stages of AD, which helps revealing microstructural and metabolite profile during AD progression pathogenesis.
  Figure 465-04-004.  Progressive Glymphatic Impairment Across Alzheimer’s Disease Stages: A Multimodal MRI Study
Hairong Ma, Pu-Yeh Wu, Songtao Ai
Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, China
Impact: This study provides in vivo evidence of progressive glymphatic dysfunction across Alzheimer’s disease stages. MRI-derived glymphatic metrics may serve as potential biomarkers for disease staging and monitoring therapeutic efficacy.
  Figure 465-04-005.  Characteristic changes of resting-state networks in early Alzheimer's disease patients: a multi-method brain network analysis
Yi Ling, Qidong Wang, Desheng Shang, Yujie Su, Cong Wu, Jianwei Ge, Lu Han, Zhuolin He, Wenbo Xiao, Benyan Luo
First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
Impact: This study provides a more integrated view of network dysfunction in early AD. The identification of specific inter-network disconnection and altered structure-function coupling in the prodromal MCI stage offers evidence for developing neuroimaging biomarkers for early detection and differential diagnosis.
  Figure 465-04-006.  NMR and x-ray Advanced 2D/3D techniques to investigate 23Na relaxation and distribution concentration changes in AD
michela fratini, Martina Negozio, Alessandra Gianoncelli, Fabrizio Bardelli, Alessandra Maiuro, Valentina Bonanni, Benedetta Niccolini, Elena Longo, Giuliana Tromba, Maria Guidi, Yasmine Salman, Charles Nicaise, Bernard HANSEEUW, Giovanni Augusto Carlesimo, Silvia Capuani
CNR-Nanotec &Santa Lucia Foundation, Rome, Italy
Impact: This study establishes sodium (²³Na) MRI metrics as potential biomarkers of neuroinflammation in Alzheimer’s disease, enabling earlier and non-invasive detection of neurodegenerative changes, informing clinical research, and advancing neuroimaging tools for improved understanding and monitoring of AD pathophysiology.
  Figure 465-04-007.  Integrating AI-Derived Brain Volumetrics with Clinical Measures Enhances Early Alzheimer’s Disease Detection
Lisa Shi, Dongang Wang, Chun-Chien Shieh, Kyi Nue Nyo Zin, Michael Barnett, Sharon Naismith, Chenyu Wang
The University of Sydney, Sydney, Australia
Impact: AI-enabled brain volumetrics from MRI scans can modestly enhance diagnostic accuracy for AD beyond traditional clinical measures. Scalable, automated AI tool could support diagnostic assessment and early intervention in routine clinical workflows, accelerating personalised approaches to dementia diagnosis and care
  Figure 465-04-008.  Predicting brain atrophy in Alzheimer’s disease using 3D conditional rectified flow model
Jeongbeen Lee, Juhyung Park, Rokgi Hong, Jongho Lee
Seoul National University, Seoul, Korea, Republic of
Impact: This study successfully generated high-quality 3D MR images for subject-specific brain atrophy to predict Alzheimer's disease progression. Incorporating meta information improved the performances, especially in AD-spectrum subjects. Quantifying the influence of the meta information further enhanced model interpretability.
  Figure 465-04-009.  Staging of Alzheimer’s Disease Using Multi-Regional Volumetric Z-Scores and Cognitive Assessments
Lina Bacha, Punith Bidarakka Venkategowda, Keerthi Prabhu M, Jean-Philippe Thiran, Jonathan Disselhorst, Bénédicte Maréchal, Tommaso Di Noto
Siemens Healthineers International AG, Lausanne, Switzerland
Impact: Combining brain volumetry with cognitive scores improves the distinction between healthy aging, mild cognitive impairment, and Alzheimer’s disease. Volumetric measures add biological information that complement cognitive assessments, highlighting the value of using both for more accurate and individualized diagnosis.
  Figure 465-04-010.  PDDF-Net: A deep neural network for diagnosing Parkinson's Disease using QSM and T1w images
Ang Gao, Yanshuo Liu, Yin Liu, Shanshan Shan, Ruixi Zhou, Peng Wu, Feng Liu, G. Bruce Pike, Hongfu Sun, Yang Gao
Central South University, Changsha, China
Impact: This work introduces a new DL paradigm for diagnosing PD based on QSM and T1w images, which looks into the 3D volume data of patients in a slice-by-slice manner, achieving both improved explainability and diagnostic accuracy.
  Figure 465-04-011.  Structural Connectivity Alterations of Cortical Rich-Club in Parkinson’s Disease with Freezing of Gait
Gaurav Nitin Rathi, Jason Longhurst, Jessica K. Caldwell, Aaron Ritter, Zoltan Mari, Virendra Mishra
University of Alabama at Birmingham, Birmingham, United States of America
Impact: Our study identifies maladaptive strengthening of structural hub networks as a mechanism underlying freezing of gait in Parkinson's disease. Rich-Club topology may serve as an objective biomarker for early FOG risk identification, informing targeted interventions.
  Figure 465-04-012.  Edge-Centric Functional Connectivity and ALFF Reveal Dual-Track Network Alterations Across Different Cognitive States in PD
Boyu Chen, Yueluan Jiang, Fangxiao Cheng
The First Hospital of China Medical University, Shenyang, China
Impact: Integration of edge-centric functional connectivity and ALFF enables multiscale characterization of Parkinson’s disease–related cognitive decline, offering mechanistic insights into hierarchical network reconfiguration underlying impaired cognitive processing.
  Figure 465-04-013.  Anatomically-Guided Deep Learning for Early Parkinson's Disease Diagnosis Using Dual-Modal Diffusion MRI
Yu Shen, Yan Bai, 亚平 吴, Wei Wei, Xinhui Wang, xianchang zhang, Meiyun Wang
Zhengzhou University People's Hospital & Henan Provincial People's Hospital, Zhengzhou, China
Impact: Our anatomically-guided approach improves early PD diagnostic accuracy by effectively integrating multi-modal neuroimaging features. This fusion strategy utilizing anatomical knowledge provides a valuable reference paradigm for deep learning techniques in the multimodal neuroimaging field.

Back to the Program-at-a-Glance

© 2026 International Society for Magnetic Resonance in Medicine